12 February 2021 

A World Health Organization (WHO) panel has recommended that the Covid-19 vaccine developed by AstraZeneca and the University of Oxford can be used for widespread use, including in people aged over 65. Interim recommendations suggested that the vaccine be taken in two does, with a gap of of eight to 12 weeks between doses. South Africa had recently paused its rollout as a result of inefficacy data from a trial of the vaccine in the South African (501Y.V2) variant.

The US government has procured an additional 100 million doses of Moderna’s Covid-19 vaccine, bringing the total confirmed order to 300 million doses. The company has supplied 41 million doses of the vaccine to the US to date.